SRPL NSE filing

Shree Ram Proteins Limited Holds 16th AGM on March 5, 2026

The RealCase readLow impact Neutral

Shree Ram Proteins Limited held its 16th AGM on March 5, 2026. Key resolutions included adopting FY24 financial statements, appointing directors, and ratifying cost auditor remuneration for FY25. E-voting results will be announced separately.

Why it matters

The announcement details the proceedings of an AGM, which is a regular corporate event. It does not involve any significant new business developments, financial results, or strategic changes that would have a substantial impact on the company's stock or operations.

The market read

The announcement is a routine update on the proceedings of the Annual General Meeting and does not contain any specific financial performance data or forward-looking statements that would indicate a positive or negative sentiment.

Shree Ram Proteins Limited conducted its 16th Annual General Meeting (AGM) on Thursday, March 5, 2026, through video conferencing and other audio-visual means. The meeting, which commenced at 11:05 A.M. (IST) and concluded at 11:11 A.M., was held in compliance with applicable regulations and circulars from the Ministry of Corporate Affairs and SEBI.

Key management personnel present included Mr. Lalitkumar Chandulal Vasoya (Managing Director), Mr. Navin Kumar Singh (Director), Mr. Piyush Chandubhai Vasoya (Director), Mr. Krutil Kishorbhai Parakhia (Chief Financial Officer), and Mr. Bhupendra Kanjibhai Bhadani (Company Secretary). M/s. Payal Dhamecha & Associates served as the Secretarial Auditors and Scrutinizers.

The Chairman welcomed attendees and provided an overview of the company's financial performance, achievements, and future plans. The financial performance for the fiscal year 2023-24 was presented by the CFO. The auditors' report for the financial year ended March 31, 2024, contained no qualifications or comments.

During the AGM, several business items were transacted via remote e-voting. These included the adoption of audited financial statements for the year ended March 31, 2024, the appointment of a director in place of Mr. Navin Kumar Singh who retires by rotation, the regularization of Mr. Akash Sureshbbhai Gajera and Mr. Yogesh Chandubhai Dhanani as Independent Directors, and the ratification of remuneration for the cost auditors for the financial year ending March 31, 2025.

The company has appointed M/s. Payal Dhamecha & Associates as the scrutinizer for the e-voting process. The combined results of e-voting and voting during the AGM will be announced and made available on the company's website and submitted to the stock exchanges.

Filing to action

What to do with a filing like this

Shree Ram Proteins Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Shree Ram Proteins Limited. Read the original for the full detail.

View original filing